PRODUCTION OF CHRONIC CONGESTIVE-HEART-FAILURE BY RAPID VENTRICULAR PACING IN THE RABBIT

被引:23
|
作者
MASAKI, H
IMAIZUMI, T
ANDO, S
HIROOKA, Y
HARADA, S
MOMOHARA, M
NAGANO, M
TAKESHITA, A
机构
[1] KYUSHU UNIV,FAC MED,ANGIOCARDIOL RES INST,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN
[2] KYUSHU UNIV,FAC MED,CARDIOVASC CLIN,HIGASHI KU,FUKUOKA 812,JAPAN
关键词
RAPID VENTRICULAR PACING; CONGESTIVE HEART FAILURE; RABBIT;
D O I
10.1093/cvr/27.5.828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim was to produce a model of low output congestive heart failure by rapid pacing in rabbits. Methods: To perform rapid pacing in rabbits, a custom made pacemaker was developed which is light (about 80 g) and can pace at up to 400 beats.min-1 for more than two weeks. A thoracotomy was done and two electrodes were sutured onto the left ventricle. A central venous pressure line was chronically implanted. With the use of this pacemaker, rabbits were paced at 350-400 beats-min-1 for several weeks. Results: Central venous pressure increased from 1.4(SEM 0.2) to 6.4(0.5) mm Hg (p<0.01, n=14). After pacing for 16.1(1.6) d, haemodynamic studies were performed under anaesthesia with thiamylal sodium. Left ventricular end diastolic pressure was higher in the paced rabbits (n=10) than in the control rabbits which underwent sham operation but were not paced (n=6), at -0.6(0.6) v 19.3(2.0) mm Hg (p<0.01). Cardiac output [673(56) v 536(45) ml.min-1, p<0.10] and +dP/dt [1433(97) v 722(51) mm Hg.s-1, p<0.01] were lower in the paced rabbits (n=7-8) than in the control rabbits (n=6). The paced rabbits had more ascites [1.9(1.0) v 45.9(18.9) ml, p<0.05] and pleural effusion [0.4(0.3) v 12.9(6.7) ml, p<0.10] than control rabbits. Plasma noradrenaline was higher in the paced rabbits (n=11) than in the control rabbits (n=7), at 1.59(0.43) v 0.60(0.05) ng.ml-1 (p<0.05). The ratio of wet heart weight or lung weight to body weight was higher (p<0.01) in the paced rabbits than in the control rabbits. Conclusions: Chronic biventricular congestive heart failure can be produced in rabbits by rapid pacing.
引用
下载
收藏
页码:828 / 831
页数:4
相关论文
共 50 条
  • [41] THE PREVALENCE AND POSSIBLE MECHANISMS OF VENTRICULAR ARRHYTHMIAS IN CONGESTIVE-HEART-FAILURE
    BIGGER, JT
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (04): : 1039 - 1039
  • [42] CHRONIC CONGESTIVE-HEART-FAILURE - DESCRIPTION AND SURVIVAL OF 190 CONSECUTIVE PATIENTS WITH A DIAGNOSIS OF CHRONIC CONGESTIVE-HEART-FAILURE BASED ON CLINICAL SIGNS AND SYMPTOMS
    MADSEN, BK
    HANSEN, JF
    STOKHOLM, KH
    BRONS, J
    HUSUM, D
    MORTENSEN, LS
    EUROPEAN HEART JOURNAL, 1994, 15 (03) : 303 - 310
  • [43] INCESSANT VENTRICULAR-TACHYCARDIA ASSOCIATED WITH CONGESTIVE-HEART-FAILURE
    KOLETTIS, TM
    THEODORAKIS, GN
    LIVANIS, E
    ZARVALIS, E
    PARASKEVAIDIS, I
    KREMASTINOS, DT
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (11): : 2096 - 2099
  • [44] ELEVATION OF CIRCULATING AND VENTRICULAR ADRENOMEDULLIN IN HUMAN CONGESTIVE-HEART-FAILURE
    JOUGASAKI, M
    WEI, CM
    MCKINLEY, LJ
    BURNETT, JC
    CIRCULATION, 1995, 92 (03) : 286 - 289
  • [45] AMIODARONE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND ASYMPTOMATIC VENTRICULAR ARRHYTHMIA
    SINGH, SN
    FLETCHER, RD
    FISHER, SG
    SINGH, BN
    LEWIS, HD
    DEEDWANIA, PC
    MASSIE, BM
    COLLING, C
    LAZZERI, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02): : 77 - 82
  • [46] VENTRICULAR ARRHYTHMIAS ASSOCIATED WITH CONGESTIVE-HEART-FAILURE - THE ROLE FOR AMIODARONE
    SINGH, SN
    BENNETT, BH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (11): : 1109 - 1111
  • [47] THE KIDNEY IN CONGESTIVE-HEART-FAILURE
    RITZ, E
    FLISER, D
    EUROPEAN HEART JOURNAL, 1991, 12 : 14 - 20
  • [48] HYPOCALCEMIC CONGESTIVE-HEART-FAILURE
    ROWELL, WG
    KREISBERG, RA
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (03) : 396 - 398
  • [49] DIGITALIS IN CONGESTIVE-HEART-FAILURE
    DEMEIJER, PHEM
    NETHERLANDS JOURNAL OF MEDICINE, 1994, 45 (05): : 225 - 232
  • [50] NITRATES IN CONGESTIVE-HEART-FAILURE
    DUPUIS, J
    CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (03) : 501 - 507